161 related articles for article (PubMed ID: 1929449)
1. [Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
Fujita A; Inoue Y; Sasaki H; Nakajima S; Sekine K; Honda R; Asakawa M; Suzuki A
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2283-7. PubMed ID: 1929449
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
Itami S; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N; Nakagawa K
Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
Honda R; Fujita A; Inoue Y; Asakawa M; Suzuki A
Cancer Chemother Pharmacol; 1990; 26(5):373-6. PubMed ID: 2170045
[TBL] [Abstract][Full Text] [Related]
4. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
5. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Haneda H; Koizumi M; Hayashi T
Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Hayashi Y; Kato M; Matsuura T; Yamada Y; Adachi S; Ito G; Yamamoto K; Takeuchi T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
[TBL] [Abstract][Full Text] [Related]
8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
9. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
Fujii M; Segawa Y; Matsutomo S; Genba K
Gan To Kagaku Ryoho; 1990 May; 17(5):1021-5. PubMed ID: 2159266
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Recchia F; Sica G; De Filippis S; Rea S; Frati L
Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
Fujita A; Sasaki H; Mori T; Nakajima S; Sekine K; Inoue Y; Honda R; Asakawa M; Suzuki A
Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
[TBL] [Abstract][Full Text] [Related]
15. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
[TBL] [Abstract][Full Text] [Related]
20. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Zhang X; Sun Y; Feng F
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]